Stocksigma LogoStocksigma Logo

Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh)

■ Revenue: 7,976 (+5.4% YoY | +11.1% QoQ) ■ EBITDA: 89.9 (+622.6% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 1.1 (+96 bps YoY | Loss to Profit QoQ) ■

Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh)

Samrat Pharmachem Ltd · Outcome · 15 Aug 2026, 1:44 am

Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 7,976 (+5.4% YoY | +11.1% QoQ) ■ EBITDA: 89.9 (+622.6% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 1.1 (+96 bps YoY | Loss to Profit QoQ) ■ PAT: 87.6 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 2.84 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Samrat Pharmachem Ltd

All Samrat Pharmachem Ltd announcements